Skip to main content
EJNMMI Research

Table 1 SUV parameters of 68 Ga-DOTATOC PET imaging before and directly after administration of PRRT with 7.4 GBq 177 Lu-octreotate

From: Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors

 

SUV max(mean ± SD)

p value a

 

Pretreatment

Intra-therapeutic

Tumor lesions

22.5 ± 8.5

20.0 ± 10.4

0.226

Normal liver

8.5 ± 2.5

4.8 ± 2.0

0.016

Spleen

21.4 ± 8.9

5.6 ± 0.8

0.015

SUV ratio

   

  Tumor-to-liver

2.8 ± 1.3

4.7 ± 3.0

<0.001

  Tumor-to-spleen

1.2 ± 0.7

3.5 ± 1.5

<0.001

  1. aPaired t test.
Back to article page